How do clinical trials work?

Clinical trials follow a study plan, called a protocol, that explains who can take part, what will happen during the study and how the results will be measured. The protocol is written by researchers and reviewed by an independent ethics committee before the first participant is enrolled.

The journey usually starts with screening. The research team checks whether you meet the study's eligibility criteria, which can involve questions about your health history, a physical examination and sometimes blood tests or scans. Screening protects participants by making sure a study is likely to be suitable for them.

If you are eligible and decide to join, you go through informed consent. The team explains the purpose of the study, what you will be asked to do, how long it runs, the possible risks and benefits, and how your information will be protected. You sign a consent form only when your questions have been answered and you feel ready.

Many trials compare a new treatment against an existing treatment or a placebo. Participants are often assigned to groups at random, which helps make the comparison fair. In some studies neither you nor the research team knows which group you are in until the study ends. This is called blinding and it reduces bias in the results.

During the trial you attend scheduled visits where the team monitors your health, records any side effects and collects study data. Visit frequency varies widely between studies, from weekly appointments to a few check-ins a year, and some trials now include telehealth or home visits.

When the trial finishes, researchers analyse the data and report the results. Findings from trials feed into decisions by regulators about whether new treatments should be approved, which is how research eventually changes everyday care.